Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1-(5-((7h-pyrrolo(2,3-d)pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one
2. Pf-06651600
1. 1792180-81-4
2. Pf-06651600
3. Ritlecitinib
4. 1-((2s,5r)-5-((7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one
5. 2oye00pc25
6. Pf-06651600 Free Base
7. 1-[(2s,5r)-2-methyl-5-(7h-pyrrolo[2,3-d]pyrimidin-4-ylamino)piperidin-1-yl]prop-2-en-1-one
8. Pf06651600
9. Pf 06651600
10. Ritlecitinib?
11. 2-propen-1-one, 1-((2s,5r)-2-methyl-5-(7h-pyrrolo(2,3-d)pyrimidin-4-ylamino)-1-piperidinyl)-
12. Ritlecitinib [inn]
13. Unii-2oye00pc25
14. Ritlecitinib [who-dd]
15. Gtpl9559
16. Chembl4085457
17. Schembl16764638
18. Bcp24778
19. Ex-a2613
20. Example 5 [wo2015083028]
21. Zinc526061581
22. Ccg-267324
23. Db14924
24. Compound 11 [pmid: 28139931]
25. Ac-35550
26. Bp168506
27. Hy-100754
28. Cs-0020243
29. S8538
30. C91239
31. Pf06651600;pf 06651600
Molecular Weight | 285.34 g/mol |
---|---|
Molecular Formula | C15H19N5O |
XLogP3 | 2.1 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 3 |
Exact Mass | 285.15896025 g/mol |
Monoisotopic Mass | 285.15896025 g/mol |
Topological Polar Surface Area | 73.9 Ų |
Heavy Atom Count | 21 |
Formal Charge | 0 |
Complexity | 402 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Treatment of alopecia areata
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
81
PharmaCompass offers a list of Ritlecitinib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ritlecitinib manufacturer or Ritlecitinib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ritlecitinib manufacturer or Ritlecitinib supplier.
PharmaCompass also assists you with knowing the Ritlecitinib API Price utilized in the formulation of products. Ritlecitinib API Price is not always fixed or binding as the Ritlecitinib Price is obtained through a variety of data sources. The Ritlecitinib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ritlecitinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ritlecitinib, including repackagers and relabelers. The FDA regulates Ritlecitinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ritlecitinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ritlecitinib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ritlecitinib supplier is an individual or a company that provides Ritlecitinib active pharmaceutical ingredient (API) or Ritlecitinib finished formulations upon request. The Ritlecitinib suppliers may include Ritlecitinib API manufacturers, exporters, distributors and traders.
click here to find a list of Ritlecitinib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Ritlecitinib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ritlecitinib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ritlecitinib GMP manufacturer or Ritlecitinib GMP API supplier for your needs.
A Ritlecitinib CoA (Certificate of Analysis) is a formal document that attests to Ritlecitinib's compliance with Ritlecitinib specifications and serves as a tool for batch-level quality control.
Ritlecitinib CoA mostly includes findings from lab analyses of a specific batch. For each Ritlecitinib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ritlecitinib may be tested according to a variety of international standards, such as European Pharmacopoeia (Ritlecitinib EP), Ritlecitinib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ritlecitinib USP).